Form 4 for LLY Lilly (Eli)
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-01 · accession 0001861052-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-02-01 | LLY | Hernandez Edgardo | EVP, Pres, Mfg. Ops | M - OptEx | $0.00 | +3,572 | 43.3K | +9% | $0 |
| D | 2026-02-03 | 2026-02-01 | LLY | Hernandez Edgardo | EVP, Pres, Mfg. Ops | F - Tax | $1,037.15 | -1,591 | 41.7K | -4% | -$1.65M |
| D | 2026-02-03 | 2026-02-01 | LLY | Hernandez Edgardo | EVP, Pres, Mfg. Ops | M - OptEx | $0.00 | -3,572 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-01 | M | A | 3,572 | $0.00 | 43,303.44 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-01 | F | D | 1,591.45 | $1,037.15 | 41,711.98 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-02-01 | M | D | 3,572 | $0.00 | 0 | D | — · 2026-02-01 to 2026-02-01 | 3,572 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |